Intracranial aneurysm

Integer Holdings Corporation Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, October 26, 2023

PLANO, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended September 29, 2023.

Key Points: 
  • PLANO, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended September 29, 2023.
  • Third Quarter 2023 Highlights (compared to Third Quarter 2022, except as noted)
    Sales increased 18% to $405 million, with organic growth of 18%.
  • Integer’s fourth quarter 2023 outlook includes $5 million sales and $1 million adjusted operating income from InNeuroCo.
  • Electrochem sales decreased 25% in the third quarter 2023 compared to the third quarter 2022, returning to a normalized run-rate after previously higher sales from the supply chain recovery.

Minimally Invasive Procedures and Growing Geriatric Population Fuel Global Aneurysm Clips Market Growth: Aesculap, Integra LifeSciences, and Galvani Bioelectronics Among Key Players

Retrieved on: 
Friday, July 28, 2023

The global aneurysm clips market size is anticipated to reach USD 112.92 million by 2030, expanding at a CAGR of 7.36% from 2023 to 2030.

Key Points: 
  • The global aneurysm clips market size is anticipated to reach USD 112.92 million by 2030, expanding at a CAGR of 7.36% from 2023 to 2030.
  • The market is expected to grow due to the rising incidence of intracranial aneurysms, the rising adoption of minimally invasive intracranial aneurysms procedures, and the rise in the geriatric population.
  • The adoption of surgical clips both in laparoscopic procedures as well as open surgeries is anticipated to fuel the demand for aneurysm clips in the upcoming years.
  • Minimized incision size during the procedures and the duration of speedy recovery are the major factors driving the use of aneurysm clips among surgeons.

Global Embolotherapy Market Analysis/Forecasts, 2022-2023 & 2029 - Growing Patient Population With Chronic Conditions Increasing the Demand for Embolization Procedures - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 1, 2023

The radioembolization segment is expected to grow at high single digit CAGR from 2022 to 2029.

Key Points: 
  • The radioembolization segment is expected to grow at high single digit CAGR from 2022 to 2029.
  • The liquid embolization agents market is expected to grow at early teens CAGR from 2022 to 2029.
  • Factors such as the growing patient population with chronic conditions increasing the demand for embolization procedures, and technology advancements are driving the market growth, whereas, acquisitions and collaborations and emerging markets are providing growth opportunities.
  • The Embolotherapy global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.

Youmans and Winn Neurological Surgery. 4 - Volume Set. Edition No. 8: The Latest Information on the Fast-Moving Field of Neurosurgery - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 7, 2022

Widely regarded as the definitive reference in the field, Youmans and Winn Neurological Surgeryoffers unparalleled, multimedia coverage of the entirety of this complex specialty.

Key Points: 
  • Widely regarded as the definitive reference in the field, Youmans and Winn Neurological Surgeryoffers unparalleled, multimedia coverage of the entirety of this complex specialty.
  • An extensive video library contains stunning anatomy videos and videos demonstrating intraoperative procedures with more than 800 videos in all.
  • Each section contains a chapter providing an overview from experienced Section Editors, including a report on ongoing controversies within that subspecialty.
  • Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Insights on the Intracranial Aneurysm Global Market to 2027 - US Market is Estimated at $294.1 Million - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 16, 2022

The global market for Intracranial Aneurysm estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027.

Key Points: 
  • The global market for Intracranial Aneurysm estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $294.1 Million, While China is Forecast to Grow at 14.1% CAGR
    The Intracranial Aneurysm market in the U.S. is estimated at US$294.1 Million in the year 2020.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$281.1 Million by the year 2027.
  • In the global Surgical Clipping segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment.

Global Autosomal Dominant Polycystic Kidney Disease Epidemiology Forecast Report to 2032 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 7, 2022

The "Autosomal Dominant Polycystic Kidney Disease - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Autosomal Dominant Polycystic Kidney Disease - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of Autosomal Dominant Polycystic Kidney Disease, historical and forecasted epidemiology as well as Autosomal Dominant Polycystic Kidney Disease trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
  • The diagnosed prevalent cases of Autosomal Dominant Polycystic Kidney Disease are likely to change by 2032 in the forecast period 2022-2032.
  • The report provides the segmentation of the disease epidemiology for the 7MM, a total number of total Diagnosed Prevalent Cases of Autosomal Dominant Polycystic Kidney Disease, Age-specific cases of Autosomal Dominant Polycystic Kidney Disease, and Mutation-specific cases of Autosomal Dominant Polycystic Kidney Disease.

Global Interventional Neurology Market Analysis Report 2022: Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices - Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 29, 2022

The "Interventional Neurology Market Analysis by Product (Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices), by Disease (Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Ischemic Strokes), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Interventional Neurology Market Analysis by Product (Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices), by Disease (Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Ischemic Strokes), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • Enormous global target patient population is a key driver for the growth of the global interventional neurology market.
  • In 2021, the aneurysm coiling and embolization devices segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.
  • The cerebral balloon angioplasty and stenting systems segment is anticipated to grow at a profitable CAGR during the forecast period, due the launch of new products driving the market worldwide.

Cerus Endovascular Names Stephen Griffin as Chief Executive Officer

Retrieved on: 
Tuesday, July 12, 2022

FREMONT, Calif. and OXFORD, United Kingdom, July 12, 2022 /PRNewswire/ -- Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today the appointment of Stephen Griffin, Ph.D. to Chief Executive Officer, effective immediately.

Key Points: 
  • FREMONT, Calif. and OXFORD, United Kingdom, July 12, 2022 /PRNewswire/ -- Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today the appointment of Stephen Griffin, Ph.D. to Chief Executive Officer, effective immediately.
  • Dr. Griffin has been with the company since 2014 and was appointed President in 2018.
  • He was critical in assembling the current Cerus Endovascular team and indispensable in creating and establishing the "Contour" brand internationally.
  • "I am truly honored to accept this role and will continue to give my 100% effort in expanding our global footprint with our portfolio of products," stated Dr. Griffin.

RSNA: Novel Treatment Effective for Sidewall Brain Aneurysm

Retrieved on: 
Tuesday, April 19, 2022

OAK BROOK, Ill., April 19, 2022 /PRNewswire-PRWeb/ -- A novel mesh plug that has been traditionally used to treat brain aneurysms occurring where the blood vessels branch out was found to be equally effective in treating aneurysms on the side of the vessel, according to a study published April 19 in the journal Radiology.

Key Points: 
  • A common treatment involving the placement of tiny platinum coils into the aneurysm has limitations.
  • Some specialists have used it off-label for the treatment of sidewall aneurysms, a type of wide-necked aneurysm that occurs at the side of a blood vessel rather than its bifurcation tip.
  • "The results show that the WEB device is safe and effective to use for sidewall aneurysms."
  • "Our ultimate goal is to provide our patients with the best possible treatment for their brain aneurysms," he said.

Global Intracranial Aneurysm Market Research Report to 2027 - by Type, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, March 25, 2022

What is the market size and forecast of the Global Intracranial Aneurysm Market?

Key Points: 
  • What is the market size and forecast of the Global Intracranial Aneurysm Market?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Intracranial Aneurysm Market?
  • What is the market share of the leading vendors in the Global Intracranial Aneurysm Market?
  • What modes and strategic moves are considered suitable for entering the Global Intracranial Aneurysm Market?